Takeda Sues Dr. Reddy's Over Generic Actos

Law360, New York (May 25, 2010, 12:56 PM EDT) -- Japanese pharmaceutical giant Takeda Pharmaceutical Co. Ltd. has hit generic-drug maker Dr. Reddy’s Laboratories Ltd. with a patent infringement suit over blockbuster diabetes drug Actos.

Takeda lodged its complaint Thursday in the U.S. District Court for the Southern District of New York, in a continued effort to keep generic Actos off the market.

Osaka, Japan-based Takeda filed the suit after learning that Dr. Reddy’s had filed an abbreviated new drug application to market generic Actos, also known as pioglitazone hydrochloride tablets.

Actos is used in addition...
To view the full article, register now.